Diverse changes in albuminuria during treatment of essential hypertensives with an angiotensin-converting enzyme inhibitor or a calcium channel blocker

被引：0
|
作者：
Lasaridis, A [1 ]
Kopras, A [1 ]
Zebekakis, P [1 ]
Sarafidis, P [1 ]
Metallidis, S [1 ]
Tziolas, I [1 ]
Hatzistavri, L [1 ]
Diamantopoulos, A [1 ]
Kevrekidou, A [1 ]
机构：
[1] Univ Hosp, AHEPA, Thessaloniki, Greece
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [41] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [42] Aldosterone escape of angiotensin-converting enzyme inhibitor therapy in essential hypertension
    Fang, Z.
    Fu, H.
    JOURNAL OF HYPERTENSION, 2007, 25 : S394 - S394
  • [43] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [44] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [45] Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: Investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril)
    CabezasCerrato, J
    GarciaEstevez, DA
    Araujo, D
    Iglesias, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (02): : 173 - 178
  • [46] Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
    Rasmussen, Eva Rye
    Hallberg, Par
    Baranova, Ekaterina V.
    Eriksson, Niclas
    Karawajczyk, Malgorzata
    Johansson, Caroline
    Cavalli, Marco
    Maroteau, Cyrielle
    Veluchamy, Abirami
    Islander, Gunilla
    Hugosson, Svante
    Terreehorst, Ingrid
    Asselbergs, Folkert W.
    Norling, Pia
    Johansson, Hans-Erik
    Kohnke, Hugo
    Syvanen, Ann-Christine
    Siddiqui, Moneeza K.
    Lang, Chim C.
    Magnusson, Patrik K. E.
    Yue, Qun-Ying
    Wadelius, Claes
    von Buchwald, Christian
    Bygum, Anette
    Alfirevic, Ana
    Maitland-van der Zee, Anke H.
    Palmer, Colin N. A.
    Wadelius, Mia
    PHARMACOGENOMICS JOURNAL, 2020, 20 (06): : 770 - 783
  • [47] ALDOSTERONE BREAKTHROUGH DURING COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN II RECEPTOR BLOCKER IN PATIENTS WITH IGA NEPHROPATHY
    Horita, Yoshio
    Tadokoro, Masato
    Taura, Kouichi
    Taguchi, Takashi
    Miyazaki, Masanobu
    Kohno, Shigeru
    NEPHROLOGY, 2005, 10 : A37 - A37
  • [48] Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
    Eva Rye Rasmussen
    Pär Hallberg
    Ekaterina V. Baranova
    Niclas Eriksson
    Malgorzata Karawajczyk
    Caroline Johansson
    Marco Cavalli
    Cyrielle Maroteau
    Abirami Veluchamy
    Gunilla Islander
    Svante Hugosson
    Ingrid Terreehorst
    Folkert W. Asselbergs
    Pia Norling
    Hans-Erik Johansson
    Hugo Kohnke
    Ann-Christine Syvänen
    Moneeza K. Siddiqui
    Chim C. Lang
    Patrik K. E. Magnusson
    Qun-Ying Yue
    Claes Wadelius
    Christian von Buchwald
    Anette Bygum
    Ana Alfirevic
    Anke H. Maitland-van der Zee
    Colin N. A. Palmer
    Mia Wadelius
    The Pharmacogenomics Journal, 2020, 20 : 770 - 783
  • [49] Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
    Sato, A
    Saruta, T
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (09) : 781 - 788
  • [50] Zinc metabolism in essential hypertension and during angiotensin-converting enzyme inhibitor therapy - Preliminary report
    Peczkowska, M
    Kabat, M
    JanaszekSitkowska, H
    Mirocha, M
    Pulawska, M
    Sznaiderman, M
    TRACE ELEMENTS AND ELECTROLYTES, 1997, 14 (02): : 82 - 86
12345